Literature DB >> 27247833

Bipolar II Disorder Masked by Substance Use.

Kanaklakshmi Masodkar1, Stephen Manning1, Terry McMahon1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27247833      PMCID： PMC4874753          DOI： 10.4088/PCC.15l01813

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  5 in total

1.  Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression.

Authors:  Mauricio Tohen; David P McDonnell; Michael Case; Shigenobu Kanba; Kyooseob Ha; Yi Ru Fang; Hideaki Katagiri; Juan-Carlos Gomez
Journal:  Br J Psychiatry       Date:  2012-08-23       Impact factor: 9.319

2.  The duration of undiagnosed bipolar disorder: effect on outcomes and treatment response.

Authors:  Stacey McCraw; Gordon Parker; Rebecca Graham; Howe Synnott; P B Mitchell
Journal:  J Affect Disord       Date:  2014-07-19       Impact factor: 4.839

Review 3.  Co-occurring psychiatric disorders and alcoholism.

Authors:  J Stephen Rich; Peter R Martin
Journal:  Handb Clin Neurol       Date:  2014

Review 4.  Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis.

Authors:  David J Bond; Melissa M Noronha; Marcia Kauer-Sant'Anna; Raymond W Lam; Lakshmi N Yatham
Journal:  J Clin Psychiatry       Date:  2008-10       Impact factor: 4.384

5.  Review of olanzapine in the management of bipolar disorders.

Authors:  Meera Narasimhan; Travis O Bruce; Prakash Masand
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.